New study tracks nasal IVIG for long COVID in Immune-Weak patients
NCT ID NCT06992401
First seen Jan 04, 2026 · Last updated May 01, 2026 · Updated 28 times
Summary
This study collects real-world health data from 50 adults with Long COVID and a weakened immune system (like low antibody levels) who receive intranasal IVIG treatment through their own doctors. Researchers will track changes in fatigue, brain fog, and breathing over 12 weeks. No experimental treatment is given by the study—it only gathers information to learn if this approach might help.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.